Wikipedia -WSS

Wikipedia

author：explore 2025-09-06 05:39:47 - browse：33767

Adam's take main illustration — Molly Ferguson/STAT

The eye disease physician in charge of a committee that flagged a rare but severe side effect involving a newly approved drug from Apellis Pharmaceuticals has financial ties to a competing drugmaker. The conflict raises questions about his supervision of an emerging safety issue for patients and its impact on the financial health of Apellis.

Peter Kaiser, a retinal disease expert who runs the Cole Eye Institute at the Cleveland Clinic, failed to report consulting fees and stock ownership in Iveric Bio on a financial disclosure form maintained by the American Society of Retina Specialists, or ASRS. Iveric Bio is developing a treatment for geographic atrophy, a common, age-related cause of vision loss and the same indication for which the Apellis drug was approved.

The financial conflict, which was undisclosed until after Kaiser was contacted about it by STAT, is relevant because Kaiser also chairs a committee of the ASRS responsible for monitoring the safety of retina drugs and devices. On July 15, Kaiser’s committee sent a letter to member doctors, alerting them to reports of eye inflammation in people receiving injections of Syfovre, the treatment recently approved and launched by Apellis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： NIH launches clinical trials and new research office for long Covid

leisure time

WSS

Adam's Biotech Scorecard: Do Sarepta's exon

Insmed lung disease drug hits target in key Phase 3 trial

Amazon expands telehealth clinic nationwide

Stigma and the return of syphilis

NIH launches clinical trials and new research office for long Covid

Latest bird flu infection made farmworker sicker than earlier cases

focus

Wikipedia

focus

Virginia high school admissions case could be legal follow

Sage hopes for a blockbuster in antidepressant now before FDA

Cancer drug shortages should be causing more outrage

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

In Memoriam: Notable people who died in 2023

Do more moles mean more problems? Not so, says new study

How to save PrEP access — and even expand it

Lawsuit alleges UnitedHealth Group unit illegally denied claims

In age of alternative facts, a scholarly course on calling out crap

AI used to predict Covid

knowledge

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Dark money group runs ads on China biotech bill

Mitch McConnell episode has important public health takeaway

AI used to predict Covid

Latest bird flu infection made farmworker sicker than earlier cases

Scientists inch closer to single

explore

leisure time

explore

explore